Fulop T, Jacob M P, Robert L
First Department of Medicine, University Medical School, Debrecen, Hungary.
J Clin Lab Immunol. 1989 Oct;30(2):69-74.
We adapted a highly sensitive and reproducible ELISA technique for the determination of anti-elastin peptide antibodies of IgG type AEAb-IgG) and IgM type AEAb-IgM) in human sera. The determination was performed in the sera of 265 normal and diseased persons. The pathologies studied included obliterative arteriosclerosis of the legs, ischemic heart disease, stroke, diabetes mellitus, type IIb and IV hyperlipoproteinemia and hypertension. No clearcut correlation could be found between AEAb and age. In contrast, in arteriosclerotic patients and especially in obliterative arteriosclerosis of the legs and ischemic heart disease, the concentration of AEAb-IgG was significantly increased. The AEAb-IgM showed no change in the studied diseases. Both types of AEAb were decreased in type IV hyperlipoproteinemia. Anti-elastin antibodies may be involved in the pathomechanisms of the above diseases and the determination of antibody concentrations may be of some help in obliterative arteriosclerotic diseases.
我们采用了一种高度灵敏且可重复的酶联免疫吸附测定(ELISA)技术,用于检测人血清中IgG型抗弹性蛋白肽抗体(AEAb-IgG)和IgM型抗弹性蛋白肽抗体(AEAb-IgM)。检测在265名正常人和病人的血清中进行。所研究的病症包括下肢闭塞性动脉硬化、缺血性心脏病、中风、糖尿病、IIb型和IV型高脂蛋白血症以及高血压。未发现AEAb与年龄之间存在明确的相关性。相比之下,在动脉硬化患者中,尤其是下肢闭塞性动脉硬化和缺血性心脏病患者,AEAb-IgG的浓度显著升高。在所研究的疾病中,AEAb-IgM未出现变化。IV型高脂蛋白血症患者的两种AEAb均降低。抗弹性蛋白抗体可能参与了上述疾病的发病机制,抗体浓度的测定可能对闭塞性动脉硬化疾病有一定帮助。